Guidance
COVID-19 Vaccine Explainer - COMIRNATY® (Tozinameran)
COMIRNATY® is a messenger RNA (mRNA) based vaccine against coronavirus disease 2019 (COVID-19). The mRNA instructs the cell to produce proteins of the S antigen (a piece of the spike protein unique to SARS-CoV-2) to stimulate an immune response. Efficacy shown in clinical trials in participants with or without evidence of prior infection with SARS-CoV-2 and who received the full series of vaccine (2 doses) was approximately 95% based on a median follow-up of two months.
Authors
Languages
- English
Publication year
2021
Type
Guidance
Categories
- Vaccines & delivery devices
Diseases
- COVID-19
